Skip to search formSkip to main contentSkip to account menu

leumorphin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
To clarify the effects of opioid peptides, and in particular the effects of kappa‐receptor agonists on the activity of supraoptic… 
1988
1988
To elucidate the role of leumorphin, a kappa-agonist derived from proenkephalin-B (neoendorphin/dynorphin precursor), in the… 
1988
1988
The effects of leumorphin, a K-agonist derived from proenkephalin B (neoendorphin and dynorphin precursor), on vasopressin… 
1988
1988
To investigate the role of leumorphin, a kappa-opioid agonist derived from proenkephalin B (neoendorphin/dynorphin precursor) in… 
1986
1986
Leumorphin is a 29-amino-acid peptide derived from preproenkephalin B. Intracerebroventricular (i.c.v.) injection of leumorphin… 
1986
1986
The effect of intracerebroventricular (i.c.v.) administration of leumorphin on basal blood pressure and angiotensin II (AII… 
1985
1985
The effect of leumorphin (LM), one of big leu-enkephalins derived from preproenkephalin B, on PRL secretion was studied in the…